Capricor Therapeutics
CAPR
CAPR
29 hedge funds and large institutions have $8.87M invested in Capricor Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
23% less call options, than puts
Call options by funds: $932K | Put options by funds: $1.21M
Holders
29
Holding in Top 10
–
Calls
$932K
Puts
$1.21M
Top Buyers
| 1 | +$397K | |
| 2 | +$104K | |
| 3 | +$78.1K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$73.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$39K |
Top Sellers
| 1 | -$732K | |
| 2 | -$64K | |
| 3 | -$60.3K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$54.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$40.9K |